| Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma JC Bendell, SM Domchek, HJ Burstein, L Harris, J Younger, I Kuter, ... Cancer 97 (12), 2972-2977, 2003 | 974 | 2003 |
| Clinical and biologic implications of recurrent genomic aberrations in myeloma R Fonseca, E Blood, M Rue, D Harrington, MM Oken, RA Kyle, ... Blood 101 (11), 4569-4575, 2003 | 935 | 2003 |
| Pneumonia in intubated patients: role of respiratory airway care. J Rello, R Sonora, P Jubert, A Artigas, M Rué, J Vallés American journal of respiratory and critical care medicine 154 (1), 111-115, 1996 | 738 | 1996 |
| High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene MI Torres-Arzayus, JF de Mora, J Yuan, F Vazquez, R Bronson, M Rue, ... Cancer cell 6 (3), 263-274, 2004 | 430 | 2004 |
| Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer S Signoretti, L Di Marcotullio, A Richardson, S Ramaswamy, B Isaac, ... The Journal of clinical investigation 110 (5), 633-641, 2002 | 410 | 2002 |
| Mineral metabolism parameters throughout chronic kidney disease stages 1–5—achievement of K/DOQI target ranges L Craver, MP Marco, I Martínez, M Rue, M Borràs, ML Martín, F Sarró, ... Nephrology Dialysis Transplantation 22 (4), 1171-1176, 2007 | 363 | 2007 |
| Survival in patients with nosocomial pneumonia: impact of the severity of illness and the etiologic agent J Rello, M Rue, P Jubert, G Muses, R Sonora, J Valles, MS Niederman Critical care medicine 25 (11), 1862-1867, 1997 | 301 | 1997 |
| Mortality probability models for patients in the intensive care unit for 48 or 72 hours: a prospective, multicenter study S Lemeshow, J Klar, D Teres, JS Avrunin, SH Gehlbach, J Rapoport, ... Critical care medicine 22 (9), 1351-1358, 1994 | 296 | 1994 |
| Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses O Garin, M Ferrer, À Pont, M Rué, A Kotzeva, I Wiklund, E Van Ganse, ... Quality of Life Research 18, 71-85, 2009 | 269 | 2009 |
| Customized probability models for early severe sepsis in adult intensive care patients JR Le Gall, S Lemeshow, G Leleu, J Klar, J Huillard, M Rué, D Teres, ... Jama 273 (8), 644-650, 1995 | 264 | 1995 |
| Evaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosa J Rello, P Jubert, J Valles, A Artigas, M Rue, MS Niederman Clinical infectious diseases 23 (5), 973-978, 1996 | 247 | 1996 |
| ETV6 mutations in early immature human T cell leukemias P Van Vlierberghe, A Ambesi-Impiombato, A Perez-Garcia, JE Haydu, ... Journal of Experimental Medicine 208 (13), 2571-2579, 2011 | 243 | 2011 |
| Initial immunoglobulin M ‘flare’after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia: an Eastern Cooperative Oncology Group Study IM Ghobrial, R Fonseca, PR Greipp, E Blood, M Rue, DH Vesole, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 236 | 2004 |
| Multicenter phase 2 trial of rituximab for Waldenström macroglobulinemia (WM): an Eastern Cooperative Oncology Group Study (E3A98) MA Gertz, M Rue, E Blood, LS Kaminer, DH Vesole, PR Greipp Leukemia & lymphoma 45 (10), 2047-2055, 2004 | 209 | 2004 |
| Multidimensional independent predictors of cancer-related fatigue SS Hwang, VT Chang, M Rue, B Kasimis Journal of pain and symptom management 26 (1), 604-614, 2003 | 209 | 2003 |
| Impact of diversity of antibiotic use on the development of antimicrobial resistance A Sandiumenge, E Diaz, A Rodriguez, L Vidaur, L Canadell, M Olona, ... Journal of Antimicrobial Chemotherapy 57 (6), 1197-1204, 2006 | 200 | 2006 |
| Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia P Van Vlierberghe, A Ambesi-Impiombato, K De Keersmaecker, M Hadler, ... Blood, The Journal of the American Society of Hematology 122 (1), 74-82, 2013 | 175 | 2013 |
| Phase III study of PSC‐833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory … WR Friedenberg, M Rue, EA Blood, WS Dalton, C Shustik, RA Larson, ... Cancer 106 (4), 830-838, 2006 | 174 | 2006 |
| Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer E Vilaprinyo, C Forne, M Carles, M Sala, R Pla, X Castells, L Domingo, ... PloS one 9 (2), e86858, 2014 | 158 | 2014 |
| Identification of factors that influence tolerance of upper gastrointestinal endoscopy R Campo, E Brullet, A Montserrat, X Calvet, J Moix, M Rué, M Roqué, ... European journal of gastroenterology & hepatology 11 (2), 201-204, 1999 | 152 | 1999 |
